Mangoceuticals, Inc.
corporate_fare Company Profile
Mangoceuticals, Inc. (NASDAQ:MGRX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 28 items for MGRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 10 rated 8 or above. Recent SEC coverage for MGRX spans 10-Q, 8-K, PRE 14A, 424B5.
Recent high-impact activity:
- Mangoceuticals Q3 10-Q: $8.3M Nine-Month Loss, $659K Cash, Going Concern Doubt
- Mangoceuticals Sets Series D Terms: $15 Liquidation Preference, 8% Cash Dividends, 3-Year Conversion Lock
- Mangoceuticals Seeks Up to $10M in Tokenized 8% Preferred Stock Sale
- Mangoceuticals Clears Path for Up to $10M Series D Preferred Offering
- Mangoceuticals Seeks 1-for-2 to 1-for-25 Reverse Split to Hold Nasdaq Listing
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 53,343 shares in MGRX as of the October 30, 2026 settlement, a 41.7% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 5.4% of MGRX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for MGRX, detected from its recent SEC filings · based on capital-structure filings through 2026-10-09.
Registered Direct Offering Priced · Warrant Terms
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →